代谢比率和SNP与特拉马多尔相关的死亡有关
Sanaa M Aly1,2, Florian Hakim3,4, Camille Richeval3,4
1Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt. sasydayem@hotmail.com.
International journal of legal medicine
|July 17, 2023
概括
在CYP2D6,CYP2B6和CYP3A4的遗传变异影响了特拉马多尔 (TR) 的代谢. 特定的多态性与改变的代谢比率相关,并可能增加TR毒性的风险,特别是在过量服用的情况下.
科学领域:
- 药物基因组学 药物基因组学
- 毒理学 毒理学 毒理学
- 遗传学 遗传学 是一个
背景情况:
- 特拉马多尔 (TR) 的新陈代谢依赖于多形酶,特别是CYP2D6,CYP2B6和CYP3A4.
- 这些酶的遗传变异可以显著影响药物反应和毒性.
- 了解这些遗传影响对于解释与特拉马多尔相关的死亡事件至关重要.
研究的目的:
- 鉴定和分析41个基因变异在CYP2D6,CYP2B6和CYP3A4基因的个人谁死于特拉马多尔 (TR) 相关原因.
- 调查这些遗传变异与特拉马多尔及其主要代谢物的代谢比率之间的相关性.
- 探索特拉马多尔过量服用中特定遗传多态的潜在毒理学影响.
主要方法:
- 来自48例TR相关死亡病例的血液样本的分析.
- 使用LC-MS/MS.对特拉马多尔,O-desmethyltramadol (M1) 和N-desmethyltramadol (M2) 的量化.
- 使用HaloPlex目标丰富系统对CYP2D6,CYP2B6和CYP3A4中的41个单核酸多态体 (SNPs) 进行基因定型.
主要成果:
- 在特定基因型 (CYP2D6中的rs35742686和CYP3A4中的rs35599367) 和改变的代谢比率 (M2/M1和TR/M2) 之间发现了显著的关联.
- 两种SNP (CYP2D6中的rs1058172和CYP2B6中的rs4803419) 在特拉马多尔过量组中过度表现.
- 这些发现表明这些遗传变异在特拉马多尔毒性的潜在作用.
结论:
- 在CYP2D6,CYP2B6和CYP3A4中的遗传多态可能会影响特拉马多尔代谢,并导致毒性风险增加.
- 确定的特定SNP可以作为特拉马多尔相关不良事件的潜在生物标志物.
- 建议对更大的队列进行进一步验证,以确认这些药物遗传学关联.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
206
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
206
Factors Affecting Drug Biotransformation: Biological
180
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
180
Nonlinear Pharmacokinetics: Causes of Nonlinearity
244
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
244
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Nonlinear Pharmacokinetics: Role of Transporters
73
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
73


